Long-lasting dermatological lesions after tiludronate therapy.
Roux
C
C
Department of Rheumatology, René Descartes University, Cochin Hospital, Paris, France.
Listrat
V
V
Villette
B
B
Lessana-Leibowitch
M
M
Ethgen
D
D
Pelissier
C
C
Dougados
M
M
Amor
B
B
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000150:complications; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology*; D016032:Randomized Controlled Trials as Topic; D012867:Skin / Q000187:drug effects / Q000473:pathology*
D000305:Adrenal Cortex Hormones; D004164:Diphosphonates; C058651:tiludronic acid